Adage Capital Partners GP »

Xilio Therapeutics shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1M 112k 9.58

More positions owned by Adage Capital Partners GP

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
ConocoPhillips (COP)

View all positions for Adage Capital Partners GP

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
OrbiMed Advisors
Frazier Life Sciences Management
Stonepine Capital Management
Vanguard Capital Management
Sio Capital Management
Adage Capital Partners GP
Merck & Co
Renaissance Technologies
Morgan Stanley
Geode Capital Management
Citadel Advisors
Vanguard Fiduciary Trust
Bridgeway Capital Management
Two Sigma Investments

View all funds holding Xilio Therapeutics